NUS Nu Skin Enterprises, Inc. Common Stock
NYSE · Consumer products · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 8월 10, 2026NUS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
NUS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
Nu Skin Enterprises, Inc. Common Stock 정보 위키백과 회사 개요
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | NUS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05년 평균 ≈30.6 | ≈30.6 | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | NUS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 매출 총이익률 (TTM) | 69.2%5년 평균 ≈70.6% | ≈70.6% | 68.4% | 약함 | |
| 영업이익률 (TTM) | -0.76%5년 평균 ≈2.4% | ≈2.4% | 2.4% | 약함 | |
| EBITDA 마진 (TTM) | 2.9%5년 평균 ≈5.8% | ≈5.8% | 2.4% | 약함 | |
| 세전 마진 (TTM) | -1.9%5년 평균 ≈3.4% | ≈3.4% | -2.0% | 약함 | |
| 순이익률 (TTM) | -15.7%5년 평균 ≈2.6% | ≈2.6% | -3.7% | 약함 | |
| ROA (TTM) | -16.9%5년 평균 ≈3.2% | ≈3.2% | 5.6% | 최상위권 | |
| ROE (TTM) | -32.5%5년 평균 ≈6.2% | ≈6.2% | 13.7% | 최상위권 | |
| ROIC | 5.2%5년 평균 ≈3.2% | ≈3.2% | 5.2% | 동일 |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | NUS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 (MRQ) | 0.45년 평균 ≈0.5 | ≈0.5 | 0.1 | 높은 부채 | |
| 유동비율 (MRQ) | 2.05년 평균 ≈2.0 | ≈2.0 | 2.0 | 동일 | |
| 당좌 비율 (MRQ) | 0.95년 평균 ≈0.9 | ≈0.9 | 0.6 | 강한 유동성 | |
| 장기 부채 / 자기 자본 (MRQ) | 0.45년 평균 ≈0.4 | ≈0.4 | · | · |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | NUS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | -14.3%5년 평균 ≈-10.2% | ≈-10.2% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | -12.6%5년 평균 ≈-11.7% | ≈-11.7% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | -10.5% | · | · | · | |
| EPS YoY | -91.8%5년 평균 ≈-46.9% | ≈-46.9% | · | · | |
| Net Income YoY (순이익 YoY) | -91.8%5년 평균 ≈-47.9% | ≈-47.9% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3년) | 15.4% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5년) | -2.6% | · | · | · | |
| Net Income CAGR 3Y (순이익 CAGR 3년) | 15.2% | · | · | · | |
| Net Income CAGR 5Y (순이익 CAGR 5년) | -3.5% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | NUS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 1.05년 평균 ≈1.2 | ≈1.2 | 1.0 | 동일 | |
| Inventory Turnover (재고 회전율) | 2.55년 평균 ≈2.1 | ≈2.1 | 3.1 | 약함 | |
| Receivables Turnover (매출 채권 회전율) | 32.95년 평균 ≈39.8 | ≈39.8 | 15.7 | 최상위권 | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$530.4K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
| 배당락일 | 금액 | 통화 | 수익률 |
|---|---|---|---|
| 8월 28, 2026 | $0.06 | USD | ≈4.9% |
| 5월 29, 2026 | $0.06 | USD | ≈4.1% |
| 2월 27, 2026 | $0.06 | USD | ≈2.8% |
| 11월 28, 2025 | $0.06 | USD | ≈2.4% |
| 8월 29, 2025 | $0.06 | USD | ≈2.0% |
| 5월 30, 2025 | $0.06 | USD | ≈2.8% |
| 2월 24, 2025 | $0.06 | USD | ≈3.1% |
| 11월 29, 2024 | $0.06 | USD | ≈3.3% |
| 8월 30, 2024 | $0.06 | USD | ≈6.4% |
| 5월 31, 2024 | $0.06 | USD | ≈6.7% |
| 2월 23, 2024 | $0.06 | USD | ≈9.8% |
| 11월 22, 2023 | $0.39 | USD | ≈9.2% |
| 8월 24, 2023 | $0.39 | USD | ≈6.7% |
| 5월 25, 2023 | $0.39 | USD | ≈4.5% |
| 2월 24, 2023 | $0.39 | USD | ≈3.8% |
| 11월 23, 2022 | $0.39 | USD | ≈4.0% |
| 8월 25, 2022 | $0.39 | USD | ≈3.5% |
| 5월 26, 2022 | $0.39 | USD | ≈3.4% |
| 2월 25, 2022 | $0.39 | USD | ≈3.2% |
| 11월 24, 2021 | $0.38 | USD | ≈3.3% |
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 8월 5, 2026 | $0.20 | $0.20 | -0.99% |
| 2026년 3월 31일 | $0.14 | $0.15 | -7.6% | |
| 2025년 12월 31일 | $0.29 | $0.30 | -4.3% | |
| 2025년 9월 30일 | $0.34 | $0.30 | 12.2% | |
| 2025년 6월 30일 | $0.43 | $0.25 | 73.7% | |
| 2025년 3월 31일 | $0.23 | $0.13 | 73.8% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $29.53 | $34.88 | $39.49 | $44.05 | $52.42 | $48.93 | $43.28 | $47.44 | $41.55 | · | · | |
| Cash Flow / Share | $1.60 | $2.25 | $2.38 | $2.14 | $2.75 | $7.19 | $3.18 | $3.59 | $5.52 | · | $5.45 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.35 | |
| EPS (TTM) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | · | $2.25 |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | · | 49,398,000 | 49,441,000 | 49,764,000 | · | 49,707,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 49,931,000 | 49,644,000 | · | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | · | 50,310,000 | 49,499,000 | 50,328,000 | · | 49,733,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 50,161,000 | 50,058,000 | · | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $6.59 | $6.49 | · | $7.24 | $7.80 | $7.24 | · | $8.65 | $8.84 | $8.42 | · | $10.00 | $9.97 | $9.62 | · | $10.71 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $0.01 | · | · | · | $0.07 | · | · | · | $-0.44 | · | · | |
| EPS (TTM) | $-4.49 | $1.08 | · | $2.18 | $2.01 | $-0.80 | · | $-2.08 | $-2.99 | $-0.07 | · | $1.18 | $1.41 | $1.54 | · | $0.75 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.38B | $1.44B | · | $1.56B | $1.63B | $1.68B | · | $1.78B | $1.84B | $1.90B | · | $2.00B | $2.04B | $2.10B | · | $2.38B | |
| Net Income TTM | $-216M | $55M | · | $110M | $101M | $-39M | · | $-103M | $-148M | $-3M | · | $59M | $70M | $77M | · | $38M | |
| P/E | -1.2 | 6.7 | · | 5.6 | 4.0 | -9.1 | · | -3.5 | -3.5 | -197.6 | · | 18.0 | 23.5 | 25.5 | · | 44.5 | |
| Earnings Yield | -85.0% | 14.8% | · | 17.9% | 25.2% | -11.0% | · | -28.2% | -28.4% | -0.51% | · | 5.6% | 4.2% | 3.9% | · | 2.2% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · | |
| Annual Payout | $12M | $12M | · | $12M | $12M | $12M | · | $28M | $45M | $61M | · | $77M | $77M | $77M | · | $77M |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 매출 | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| 매출 총이익률 % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| 영업이익률 % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| 순이익 | $160M | $-147M | $9M | $105M | $147M |
| 희석 EPS | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| 유동비율 | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| 당좌 비율 | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $46M | $70M | $60M | $49M | $73M |
기관 투자자 (13F) 183개의 제출자 · $241.8M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 28 (+2 이전 분기 대비) | 35 (+9 이전 분기 대비) | 52 (-13 이전 분기 대비) | 60 (-4 이전 분기 대비) | -182K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $41,729,944 | 4,337,832 | 17.26% | 주식 |
| BlackRock, Inc. | $22,787,834 | 4,315,878 | 9.42% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $12,150,906 | 2,301,308 | 5.02% | 주식 |
| Coppell Advisory Solutions LLC | $11,266,612 | 235 | 4.66% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,822,104 | 2,049,641 | 4.47% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $9,486,817 | 1,796,745 | 3.92% | 주식 |
| Prescott Group Capital Management, L.L.C. | $9,475,530 | 1,794,608 | 3.92% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9,170,600 | 1,736,856 | 3.79% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $8,488,614 | 1,607,692 | 3.51% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7,671,507 | 1,452,937 | 3.17% | 주식 |
| CastleKnight Management LP | $7,337,262 | 1,389,633 | 3.03% | 주식 |
| TWO SIGMA ADVISERS, LP | $7,314,086 | 760,300 | 3.02% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $6,702,971 | 1,269,191 | 2.77% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $6,170,388 | 1,168,634 | 2.55% | 주식 |
| STATE STREET CORP | $5,330,941 | 1,009,648 | 2.20% | 주식 |
| PRUDENTIAL FINANCIAL INC | $4,890,795 | 926,287 | 2.02% | 주식 |
| MORGAN STANLEY | $4,781,192 | 905,527 | 1.98% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $4,024,565 | 789,131 | 1.66% | 주식 |
| CITADEL ADVISORS LLC | $3,456,167 | 654,577 | 1.43% | 주식 |
| GOLDMAN SACHS GROUP INC | $3,266,432 | 618,642 | 1.35% | 주식 |
| Bank of New York Mellon Corp | $2,862,799 | 542,197 | 1.18% | 주식 |
| NORTHERN TRUST CORP | $2,191,300 | 415,019 | 0.91% | 주식 |
| Allianz Asset Management GmbH | $2,074,074 | 392,817 | 0.86% | 주식 |
| D. E. Shaw & Co., Inc. | $2,010,043 | 380,690 | 0.83% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,674,151 | 317,074 | 0.69% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,627,908 | 308,316 | 0.67% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $1,590,690 | 301,267 | 0.66% | 주식 |
| Empowered Funds, LLC | $1,321,542 | 250,292 | 0.55% | 주식 |
| AXA Investment Managers S.A. | $1,307,268 | 107,241 | 0.54% | 주식 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1,212,651 | 166,573 | 0.50% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,081,872 | 204,900 | 0.45% | 주식 |
| Nuveen, LLC | $951,700 | 180,246 | 0.39% | 주식 |
| Vanguard Global Advisers, LLC | $936,603 | 177,387 | 0.39% | 주식 |
| FIRST TRUST ADVISORS LP | $925,594 | 175,302 | 0.38% | 주식 |
| Russell Investments Group, Ltd. | $888,036 | 168,189 | 0.37% | 주식 |
| XTX Topco Ltd | $823,379 | 155,943 | 0.34% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803,590 | 152,195 | 0.33% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $799,852 | 151,487 | 0.33% | 주식 |
| JPMORGAN CHASE & CO | $751,441 | 142,588 | 0.31% | 주식 |
| LAZARD ASSET MANAGEMENT LLC | $728,614 | 137,995 | 0.30% | 주식 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670,856 | 127,056 | 0.28% | 주식 |
| UBS Group AG | $647,482 | 122,629 | 0.27% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628,125 | 118,963 | 0.26% | 주식 |
| ExodusPoint Capital Management, LP | $616,408 | 116,744 | 0.25% | 주식 |
| Cubist Systematic Strategies, LLC | $571,087 | 46,849 | 0.24% | 주식 |
| RITHOLTZ WEALTH MANAGEMENT | $527,566 | 99,918 | 0.22% | 주식 |
| Inspire Investing, LLC | $515,631 | 70,828 | 0.21% | 주식 |
| STRS OHIO | $511,104 | 96,800 | 0.21% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $467,376 | 64,200 | 0.19% | 주식 |
| Nebula Research & Development LLC | $460,288 | 57,608 | 0.19% | 주식 |
행동주의자 및 5% 이상 소유자 9 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2008년 2월 11일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2007년 4월 2일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2007년 3월 26일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2007년 3월 15일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2006년 12월 8일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2006년 6월 9일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2006년 5월 8일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2006년 1월 20일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2005년 12월 15일 | · | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
회사 내부자 57 명의 내부자 · 31 임원 · 25 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 2026년 3월 6일 A | 1,001,905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 2021년 6월 17일 S | 175,239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 2017년 2월 27일 A | 575,559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 2026년 3월 6일 A | 267,102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2023년 3월 2일 M | 57,146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 2015년 12월 18일 A | 34,585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 2007년 12월 20일 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 2007년 12월 20일 A | 5,625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 2007년 2월 26일 A | 6,005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 2007년 2월 26일 A | 4,549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 2005년 8월 31일 A | 11,453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 2026년 3월 6일 A | 390,746 | 0 | 0 | $0 |
| Justin S Keisel | EVP, President of Global Sales | 2026년 3월 6일 A | 160,170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 2026년 3월 6일 A | 260,818 | 1 | 0 | $52,855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 2023년 4월 21일 F | 43,204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2023년 3월 2일 M | 21,234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 2023년 3월 1일 G | 113,574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 2021년 10월 5일 S | 16,068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2021년 7월 2일 M | 47,159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 2015년 7월 6일 M | 48,111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 2011년 6월 3일 G | 3,216,458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 2009년 8월 28일 F | 3,322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 2007년 12월 20일 A | 6,984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 2007년 12월 20일 A | 11,410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 2007년 9월 4일 F | 3,230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 2007년 9월 4일 F | 4,202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 2006년 9월 1일 A | 20,750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 2005년 8월 31일 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 2005년 8월 31일 A | 1,734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 2005년 8월 31일 A | 5,987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2004년 12월 2일 G | 825,000 | 0 | 0 | $0 |
| Edwina D Woodbury | 이사 | 2026년 9월 9일 A | 62,474 | 0 | 1 | $-41,057 |
| James M Winett | 이사 | 2026년 6월 2일 S | 37,448 | 0 | 1 | $-40,481 |
| Laura Nathanson | 이사 | 2026년 6월 1일 A | 57,116 | 0 | 1 | $-18,009 |
| Emma S. Battle | 이사 | 2026년 6월 1일 A | 57,648 | 0 | 0 | $0 |
| Pisano R. Thomas | 이사 | 2026년 6월 1일 A | 116,827 | 0 | 0 | $0 |
| Mark A Zorko | 이사 | 2026년 6월 1일 A | 60,586 | 0 | 0 | $0 |
| Daniel W Campbell | 이사 | 2026년 6월 1일 A | 65,859 | 0 | 0 | $0 |
| Zheqing Shen | 이사 | 2024년 6월 7일 A | 33,195 | 0 | 0 | $0 |
| Andrew D Lipman | 이사 | 2024년 5월 28일 S | 23,225 | 0 | 0 | $0 |
| Neil H Offen | 이사 | 2019년 5월 21일 M | 10,083 | 0 | 0 | $0 |
| Nevin N Andersen | 이사 | 2019년 5월 21일 M | 34,045 | 0 | 0 | $0 |
| Zhequing Shen | 이사 | 2017년 5월 11일 A | 3,456 | 0 | 0 | $0 |
| Patricia Negron | 이사 | 2015년 5월 13일 G | 7,592 | 0 | 0 | $0 |
| Sandra Tillotson | 이사 | 2012년 5월 4일 M | 1,885,845 | 0 | 0 | $0 |
| David D. Ussery | 이사 | 2012년 2월 9일 M | 13,222 | 0 | 0 | $0 |
| Ej Jake Garn | 이사 | 2011년 5월 24일 A | 17,272 | 0 | 0 | $0 |
| Desmond C Wong | 이사 | 2007년 5월 15일 A | 1,400 | 0 | 0 | $0 |
| Christine Mccormick Day | 이사 | 2007년 5월 15일 A | 1,400 | 0 | 0 | $0 |
| Allen D Andersen | 이사 | 2006년 5월 25일 A | 2,500 | 0 | 0 | $0 |
| Paula Hawkins | 이사 | 2006년 5월 25일 A | · | 0 | 0 | $0 |
| Jose Ferreira JR | 이사 | 2006년 5월 25일 A | · | 0 | 0 | $0 |
| Nancy Roney | 10% 소유주 | 2004년 12월 3일 G | 8,541,469 | 0 | 0 | $0 |
| Nedra D Roney | 10% 소유주 | 2003년 10월 27일 S | 1,845,765 | 0 | 0 | $0 |
| Andrew Fan | · | 2007년 12월 20일 A | 22,815 | 0 | 0 | $0 |
| Melisa Quijano | · | 2007년 9월 4일 A | 6,901 | 0 | 0 | $0 |
| Takashi Bamba | · | 2003년 9월 2일 A | · | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 24 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| MYLD · Cambria ETF Trust | 0.99% | 64,849 NS | 2026년 7월 31일 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.11% | 122,929 NS | 2026년 7월 31일 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.08% | 123,628 SH | 2026년 8월 19일 | 일간 |
| VFQY · VANGUARD WELLINGTON FUND | 0.06% | 51,988 SH | 2026년 8월 19일 | 일간 |
| IWC · iShares Trust | 0.06% | 166,825 SH | 2026년 9월 11일 | 일간 |
| VDC · VANGUARD WORLD FUND | 0.03% | 570,468 SH | 2026년 8월 19일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 42,579 SH | 2026년 8월 19일 | 일간 |
| EBIT · Harbor ETF Trust | 0.02% | 424 NS | 2026년 7월 31일 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 220,644 NS | 2026년 7월 31일 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 280,867 SH | 2026년 8월 19일 | 일간 |
| IWM · iShares Trust | 0.01% | 1,309,534 SH | 2026년 9월 11일 | 일간 |
| RSSL · Global X Funds | 0.01% | 23,316 NS | 2026년 7월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 125,157 NS | 2026년 7월 31일 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.00% | 34,871 SH | 2026년 10월 1일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.00% | 42,209 NS | 2026년 7월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,155 NS | 2026년 7월 31일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 69,540 SH | 2026년 9월 11일 | 일간 |
| IWV · iShares Trust | 0.00% | 12,201 SH | 2026년 9월 3일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.00% | 9,320 NS | 2026년 7월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 562,165 SH | 2026년 8월 19일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,465,550 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,734 SH | 2026년 8월 19일 | 일간 |
| IWN · iShares Trust | · | 494,441 SH | 2026년 9월 11일 | 일간 |
| SMLF · iShares Trust | · | 109,833 SH | 2026년 9월 11일 | 일간 |
NUS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
1 명의 애널리스트 · 2026-10-01평균 목표 $12.77 +177.0%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.